Conf. Univ. Dr. George Daniel Rădăvoi

ROMURO 2021 [ Congres Online, 06/10/2021 – 08/10/2021 ]

ROMURO 2020 [ Congres Online, 10/12/2020 – 12/12/2020 ]

ROMURO 2019 [ Bucuresti, Romania, 05/06/2019 – 08/06/2019 ]

2019 Annual Meeting of the AUA [ Chicago, USA, 03/05/2019 – 06/05/2019 ]

34th Annual EAU Congress [ Barcelona, Spain, 15/03/2019 – 19/03/2019 ]

19th Central European Meeting [ Vienna, Austria, 09/05/2019 – 10/05/2019 ]

18th Central European Meeting [ Cluj Napoca, Romania, 12/10/2018 ]

ROMURO 2018 [ Cluj Napoca, Romania, 10/10/2018 – 11/10/2018 ]

32nd Annual EAU Congress London [ Londra, Regatul Unit, 24/03/2017 – 28/03/2017 ]

16th Central European Meeting [ Vienna, Austria, 06/10/2016 – 08/10/2016 ]

Urologic Surgery Clinical Immersion training [ Belinson-Rabin Medical Center, Affiliated with Sacker School of Medicine, Tel Aviv University, 19/01/2016 – 20/01/2016 ]

15th EAU Central European Meeting [ Budapesta, Ungaria, 02/10/2015 – 04/10/2015 ]

Locally advanced prostate cancer and non-muscle invasive bladder cancer [ European School of Urology, București , 19/06/2015 ]

Minimally Invasive Techniques for Laparoscopic Pelvic Surgery [ Delta Endoscopic Training Center, Bucuresti, Romania, 12/11/2014 – 14/11/2014 ]

Minimally invasive treatment of renal stones [ European School of Urology, București , 09/05/2014 ]

Nefrolitotritia Percutanata [ Universitatea de Medicina si Farmacie “Victor Babes” Timisoara, 06/03/2014 – 07/03/2014 ]

ESU Course on the placement and role of lymphadenectomy in urologic cancers [ European School of Urology, București , 17/05/2013 ]

Oncology (TCC & Adrenal) &Teaching Techniques [ American Urological Association, Atlanta , 21/05/2012 ]

Robot-Assisted Surgery: Advances in Oncology, Image Guidance and Reconstruction [ American Urological Association, Atlanta , 19/05/2012 ]

Stone surgery, lower urinary tract, prostate cancer and paediatric urology [ European School of Urology Course, Bucuresti , 07/05/2010 ]

Upper Tract, invasive bladder and penile cancer [ European School of Urology Course, Bucuresti , 29/05/2009 ]

Olympus Hands-On-Training dry lab course on laparoscopy [ European School Of Urology, Praga , 09/2008 ]

6th Course [ European Urology Residents Education Programme, Praga , 05/09/2008 – 10/09/2008 ]

Urinary lithiasis [ European School of Urology Course, Bucuresti , 13/06/2008 ]

Kidney cancer [ European School of Urology Course, Bucuresti, 29/05/2009 ]

Olympus Hands-On-Training dry lab course on laparoscopy [ European School Of Urology, Praga , 09/2008 ]

6th Course [ European Urology Residents Education Programme, Praga , 05/09/2008 – 10/09/2008 ]

Urinary lithiasis [ European School of Urology Course, Bucuresti , 13/06/2008 ]

Kidney cancer [ European School of Urology Course, Bucuresti , 13/06/2008 ]

Recent aspects of prostate cancer [ European School of Urology, Bucuresti , 17/06/2005 ] Recent aspects of Urolithiasis [ European School of Urology, Bucuresti , 17/06/2005 ]

Colegiul Medicilor din România

Asociaţia Română de Urologie

Asociaţia Europeană de Urologie

Mutographs of cancer: discovering the causes of cancer through mutational signatures, WHO Research [ 2019 – 2021 ]

Epidemiologia genetica a cancerului in Romania [ 2014 – 2017 ]

Comparatie intre biopsia prostatica sistematica si cea ţintită ultrasonografic cu ajutorul substanţei de contrast la pacienţii aflaţi ȋn tratament cu inhibitori de 5-alfa reductază [ 2012 – 2014 ]

Genetic prostate cancer variants as biomarkers of disease progression. [ 2008 – 2013 ]

Sub-investigator în studiul de fazǎ III cu protocolul 204989 [ 2019 – În curs ] Phase III, Double-Blind, Parallel-Group, Comparator-Controlled, Efficacy and Safety Study of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)

Sub-investigator în studiul de fazǎ III cu protocolul VNRX-5133-201 [ 2019 – 2021 ] A Phase 3, Randomized, Double-blind, Active Controlled Noninferiority Study Evaluating the Efficacy, Safety, and Tolerability of Cefepime/VNRX-5133 in Adults With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis

Sub-investigator în studiul de fazǎ III in studiul SPR994-301 [ 2019 – 2020 ] A Phase 3, Randomized, Double-blind,Double-dummy, Multicenter, Prospective Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients with Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)”

Sub-investigator în studiul de fazǎ III cu protocolul TP-434-021 [ 2017 – 2018 ] A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of IV Eravacycline Compared with Ertapenem in Complicated Urinary Tract Infections

Sub-investigator în studiul de fazǎ III cu protocolul B9991003 [ 2016 – În curs ] A PHASE 3, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, PARALLELARM STUDY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AXITINIB (INLYTA®) VERSUS SUNITINIB (SUTENT®) MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Sub-investigator în studiul de fazǎ III cu protocolul ACHN-490-009 [ 2016 ] A Phase 3, Randomized, Multicenter, Double-Blind Study to Evaluate the Efficacy and Safety of Plazomicin Compared with Meropenem followed by Optional Oral Therapy for the Treatment of Complicated Urinary Tract Infection (cUTI), including Acute Pyelonephritis (AP), in Adults

Sub-investigator in studiul de faza 3 cu protocolul AQX-1125-301 [ 2016 – 2018 ] The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5′-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period

Sub-investigator în studiul de fazǎ III cu protocolul 9785-CL-0335 [ 2016 – În curs ] Studiu multinaţional, de fază 3, randomizat, dublu-orb, controlat placebo, privind eficacitatea şi siguranţa enzalutamidei în combinație cu terapia de privare de androgeni (ADT) comparativ cu placebo în combinație cu ADT la pacienţi cu cancer de prostată metastatic hormono-sensibil (mHSPC)

Sub-investigator în studiul de fazǎ III cu protocolul 1409R2121 [ 2015 – 2017 ] A Multicenter, Double-blind, Randomized, Clinical Study to Assess the Efficacy and Safety of Intravenous S-649266 in Complicated Urinary Tract Infections with or without Pyelonephritis or Acute Uncomplicated Pyelonephritis Caused by Gram-Negative Pathogens in Hospitalized Adults in Comparison with Intravenous Imipenem/Cilastatin

Sub-investigator în studiul de fazǎ III cu protocolul TP-434-010 [ 2014 – 2015 ] A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared with Levofloxacin in Complicated Urinary Tract Infections

Sub-investigator în studiul de fazǎ III cu protocolul 3104007 [ 2014 – 2021 ] A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF ODM-201 IN MEN WITH HIGH-RISK NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER.

Sub-investigator în studiul de fazǎ II cu protocolul 7035-CL-0014 [ 2013 – 2015 ] A Phase II, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Forced Titration Proof of Concept Study to Assess Efficacy, Safety, Tolerability and the Therapeutic Ratio of ASP7035 in Patients With Nocturia Associated With Nocturnal Polyuria

Sub-investigator în studiul de fazǎ III cu protocolul ITCL0414 [ 2013 – 2013 ] Efficacy and safety of a single TRUS-guided intraprostatic injection of NX-1207 in patients with Lower Urinary Tract Symptoms associated with Benign Prostatic Hyperplasia: a phase III European clinical study

Sub-investigator în studiul AstraZeneca de fazǎ III cu protocolul D4280C00006 [ 2012 – 2014 ] An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime-Avibactam (CAZ-AVI, formerly CAZ104) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram-Negative Pathogens

Sub-investigator în studiul de fazǎ Ib/II cu protocolul GO27983 [ 2012 – În curs ] A Phase Ib/II Study of GDC-0068 or GDC-0980 with Abiraterone Acetate versus Abiraterone Acetatein Patients with Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy.

First Berlin Chemie Award for Best Poster Presentation [ 10/2017 ]

Genetic biomarkers related with prostate cancer: New perspectives” Sandu B.S, Jinga V., Dragomiristeanu I., Codreanu O., Nedelea S., Persu C., Radavoi D. EAU 17 Central European Meeting, Plzen

First Berlin Chemie Award for Best Poster Presentation [ 2016 ]

“Genomic aspects regarding prostate cancer aggressiveness”. B. Cheorpeaca, V. Jinga, O. Codreanu, D. Radavoi, D. Badescu, R. Petca. EAU 16th Central European Meeting, Viena, Austria

 First Prize for the Young Urologists Competition [ 10/2015 ] “New genetic perspectives in prostate and renal cancer” at the EAU 15 Central European Meeting, Budapesta, Ungaria

First Berlin Chemie Award for Best Poster Presentation [ 2014 ] „Genetic  studies on Romanian prostate cancer patients confirm genetic risk variants for prostate cancer”. A.S.C. Rascu, V. Jinga, M. Dumitrache, M. Merticariu, R. Petca, D. Radavoi, D. Badescu, EAU 14th Central European Meeting, 2014, Cracovia, Polonia

UROLOGIE PENTRU VIITORII CHIRURGI SI GINECOLOGI [2021] ISBN:978-606-13-6131-1. AUTORI: CATALIN PRICOP, VIOREL JINGA, ALIN CUMPANAS

CAPITOLELE: 4. Explorari endoscopice ale aparatului urinar (uretro-cistoscopia , ureteroscopia retrograda, nefroscopia) 13. Tumori benigne şi maligne aparat urinar (cancer renal, angiomiolipom, cancere uroteliale, tumori testiculare, tumori peniene, ) 17.Malformaţii şi afecţiuni congenitale:(hipospadias, epispadias, criptorhidia, hidrocel, varicocel) 18.Insuficienţa renală acută la bolnavul chirurgical. 19.Fistulele vezico-vaginale si uretero –vaginale si vezico-uterine

CURS ACADEMIC PENTRU ASISTENŢI MEDICALI [2018] Ed. Pim 2018 – ISBN: 978-606-13-4549-6. AUORI: CĂTĂLIN PRICOP, DRAGOŞ PUIA, DANIEL RĂDĂVOI, ADELINA MIRON, IRINA NEGRU – COAUTOR

APARATURĂ ŞI DISPOZITIVE MEDICALE [2012] Ed. Carol Davila 2012 – ISBN: 978-973708-633-4 COORDONATOR: PROF. UNIV. DR. CONF. UNIV. DR. VICTOR LORIN PURCAREA CAPITOLUL XI – Echipamente de urologie

Determining whether previous SWL for ureteric stones influences the results of ureteroscopy as the second-line treatment: A clinical study [2022] https://doi.org/10.3892/etm.2021.10960 Pricop C, Ivanuta M, Radavoi GD, Toma CV, Cumpanaş A, Jinga V, Bacalbaşa N, Puia D. Determining whether previous SWL for ureteric stones influences the results of ureteroscopy as the second-line treatment: A clinical study. Exp Ther Med. 2022 Jan;23(1):38. doi: 10.3892/etm.2021.10960. Epub 2021 Nov 11. PMID: 34849153; PMCID: PMC8613534

Levofloxacin versus Cefixime as an empiric treatment in acute bacterial prostatitis [2021] https://farmaciajournal.com/wp-content/uploads/art-07-Pricop_Radavoi_Cumpanas_682-687.pdf Cătălin Pricop, Dragoș Puia, Daniel Andone, Silviu Lațcu , George Daniel Rădăvoi, Ioan Cordoș, Viorel Jinga, Tudor Proca, Alin Cumpănaș. Levofloxacin versus Cefixime as an empiric treatment in acute bacterial prostatitis. Farmacia, 2021, Vol. 69, 4: 682-687,

Antihypertensive drugs and blood pressure variability [2021] https://doi.org/10.31925/farmacia.2021.2.2 Adriana-Mihaela Ilieşiu, Ioan Cordoș, Irina Pârvu, Ioana Verde, Andreea Stela Liteanu, Andreea Simona Hodorogea , George Daniel Rădăvoi. Antihypertensive drugs and blood pressure variability. Farmacia, 2021, Vol. 69, 2: 200-207.

Correlations between stones composition, dietary and comorbidities context of the lithiasic patient. [2020] https://doi.org/10.47162/RJME.61.4.24. Pricop C, Ivănuţă M, Stan A, Anton-Păduraru DT, Radavoi GD, Jinga V, Proca TM, Puia D. Correlations between stones composition, dietary and comorbidities context of the lithiasic patient. Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1227-1233. doi: 10.47162/RJME.61.4.24. PMID: 34171071; PMCID: PMC8343589

Antibiotic prophylaxis in transurethral resections: what are the criteria that should be followed? [2020] https://doi.org/10.31925/farmacia.2020.6.8 Cătălin Pricop, Ligia Florentina Furtunescu, Daniel Rădăvoi*,Viorel Jinga, Alin Cumpănaș, Dana-Teodora AntonPăduraru, Adelina Miron, Cristian Toma, Dragoș Puia. Antibiotic prophylaxis in transurethral resections: what are the criteria that should be followed? Farmacia, 2020, Vol. 68, 6: 1021-1028

The Complex Context of the Involvement of Vitamin D Deficiency in Obesity [2019] https://doi.org/10.37358/RC.19.10.7615 Stanescu AMA, Grajdeanu IV, Totan A, Miricescu D, Serban B, Buhas CL, Radavoi DG. The Complex Context of the Involvement of Vitamin D Deficiency in Obesity. Rev. Chim.[internet]. 2019 Oct;70(10):3654-3656.

Obesity and its Implications on Stress Urinary Incontinence [2019] https://doi.org/10.4183/aeb.2019.133 Dumitrascu MC, Stanescu AMA, Bejan C, Sandru F, Toader DO, Radavoi DG, Cotirlet A, Pusta CTJ, Diaconu CC. Obe sity and its Implications on Stress Urinary Incontinence. Rev. Chim.[internet]. 2019 Oct;70(10):3660-3662.

Obesity: a delicate issue choosing the eswl treatment for patients with kidney and ureteral stones? [2019] https://doi.org/10.4183/aeb.2019.133 Pricop C, Radavoi GD, Puia D, Vechiu C, Jinga V. Obesity: a delicate issue choosing the eswl treatment for patients with kidney and ureteral stones? Acta Endocrinol (Buchar). 2019 Jan-Mar;-5(1):133-138.. PMID: 31149074; PMCID: PMC6535322

Immunohistochemistry Particularities of Retroperitoneal Tumors [2016] https://pubmed.ncbi.nlm.nih.gov/27516020/ Rădăvoi GD, Pricop C, Jinga V, Mateş D, Rădoi VE, Jinga M, Ursu RI, Bratu OG, Mischianu DL, Iordache P. A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population. Rom J Morphol Embryol. 2016;57(2):467-75

Infected hydronephrosis: can we reduce patient suffering and costs? [2016] https://pubmed.ncbi.nlm.nih.gov/27812051/ Catalin Pricop, Dragos Puia, Oleg Mereuta, Catalin Ciuta, Liviu Todosi, Martha Orsolya,George Daniel Radavoi. In fected hydronephrosis: can we reduce patient suffering and costs? J Pak Med Assoc. 2016 Nov;66(11):1372-1377